A novel prostaglandin E receptor subtype agonist, ONO-4819, attenuates acute experimental liver injury in rats

Hepatology Research

Volumn 21, Issue 3, 2001, Pages 252-260

  Kasai, Kazuhiro ^a   Sato, Shin Ichiro ^a   Suzuki, Kazuyuki ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

7 [3 HYDROXY 2 [3 HYDROXY 4 (3 METHOXYMETHYLPHENYL) 1 BUTENYL] 5 OXOCYCLOPENTYL] 5 THIAHEPTANOIC ACID METHYL ESTER; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BIOCHEMICAL MARKER; CYTOKINE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; GALACTOSAMINE; GAMMA INTERFERON; INTERLEUKIN 8; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E4 RECEPTOR; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE DISEASE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ATTENUATION; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SYNTHESIS; EVALUATION; LIVER CELL; LIVER FUNCTION; LIVER INJURY; LIVER NECROSIS; MALE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTECTION; RAT;

EID: 0035149883     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6346(01)00103-6     Document Type: Article

References (37)

1. Fulminant hepatic failure
2. Cause and prognosis in acute liver failure
3. Physiopathology and therapy of fulminant hepatitis
4. Immune complexes in hepatitis
5. Cellular immunity and hepatitis-associated Australia antigen liver disease
6. Lethal effect of the anti-Fas antibody in mice
7. Mechanism of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis
8. Apoptotic cell death in the response of D-galactosamine-sensitized mice to lipopolysaccharide as an experimental endotoxic shock model
9. Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models
10. Role of adhesion between activated macrophages and endothelial cells in the development of two types of massive hepatic necrosis in rats
11. Leukocyte adhesion molecules in the liver and plasma cytokine levels in endotoxin-induced rat liver injury
12. Interleukin-10 inhibits hepatic injury and tumor necrosis factor-α and interferon-γ mRNA expression induced by staphylococcal enterotoxin B or lipopolysaccharide in galactosamine-sensitized mice
13. Involvement of tumor necrosis factor-α in development of hepatic injury in galactosamine-sensitized mice
14. Interferon-γ receptor deficient mice are resistant to endotoxic shock
15. Beneficial effect of cyclosporin A on acute hepatic injury induced by galactosamine and lipopolysaccharide in rats
16. Prostanoid receptors: Properties and functions
17. Cyto-protection by prostaglandins in rats
18. Prostaglandin protection of carbon tetrachloride induced liver cell necrosis in the rat
19. The protective effects of prostaglandin E1 in an experimental massive hepatic cell necrosis model
20. Hepatic protection by 16, 16′-dimethyl prostaglandin E2 (DMPG) against acute afratoxin B1-induced injury in the rat
21. Hepatocyte membrane stabilization by prostaglandins E1 and E2: Favorable effects on rat liver injury
22. Effect of prostaglandin E1 on experimental acute hepatic failure in rabbits: Prostaglandin E1 prevents the development of multiple-organ failure
23. Treatment of fluminant hepatic failure with a continuous infusion of prostin VT (PGE1)
24. Biochemical and clinical response of fluminant viral hepatitis to administration of prostaglandin E
25. A double-blind comparative study on G-511 (PGE1) in severe type of acute hepatitis
26. A study on the clinical efficacy and underlying mechanism of prostaglandin E1 in patients with acute severe hepatitis
27. International union of pharmacology classification of prostanoid receptors properties, distribution, and structure of the receptors and their subtypes
28. The roles of PGE2 receptor EP4 subtype on cytokine regniation and its related disease
29. Cytoprotective effect of 16, 16′-dimethyl prostaglandin E2 and some drugs on an acute galactsamine induced liver damage in rat
30. Prostaglandin E1 protects against ischemia reperfusion injury of the liver by inhibition of neutrophil adherence to endothelial cells
31. The release of tumor necrosis factor from endotoxin stimulated rat Kupffer cells is regulated by prostaglandin E2 and dexamethasone
32. Localizationof functional prostaglandin E2 receptors EP3 and EP4 in the nuclear envelope
33. Characterization of the LPS- stimulated expression of EP2 and EP4 prostaglandin E receptors in mouse macrophage-like cell line J774. I
34. Molecular cloning and characterization of four rat prostaglandin E2 prostanoid receptor subtypes
35. Enhanced tumor necrosis factor and interleukin-1 in fulminant hepatic failure
36. Serum levels of soluble Fas ligandin patients with acute and fulminant hepatitis: Relationship with soluble Fas, tumor necrosis factor-α and TNF-receptor-1
37. Induction of CINC (interleukin-8) production in rat liver by non-parenchymal cells